- Home
- Your Messages
-
Smartest Doc
Daily Quiz CompetitionTest your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
New! PHYSICIAN REVIEW
Thousands of questions to assess your knowledge and aid exam prep!
- Physician Jobs (1894)
- More
- Other Specialty
Pulmonology - Cystic Fibrosis News & Articles
Are you looking to stay current with all of the latest Pulmonology news articles and research? Look no further! MDLinx Pulmonology medical editors extensively research respiratory medical journals to find the most beneficial Pulmonology clinical literature. Topics range from: Pediatric Pulmonology, Sleep Disorders, Asthma, COPD, Cystic Fibrosis and much more. In a matter of minutes, Pulmonologists and their staff can stay up to date with the most current published information.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We also feature clinical pearls from our Internal Medicine Physician Review. You can also get the latest updates on salary information, search available Pulmonology jobs, view upcoming Pulmonology and CME conferences and earn some extra cash by participating in Market Research opportunities.
Not yet an MDLinx.com Member??? Sign up now to gain access to MDLinx exclusive content, email alerts that keep you current on the latest medical news, research, and clinical articles on the topics of your choice, special communications and offers from MDLinx and our sponsors. Plus, you can now post your CV to the MDLinx Career Center to be viewed top medical recruiters who will help you find your next dream job.
Your Unread Messages in Pulmonology
See All >> Messages include industry-sponsored communications and special communications from MDLinx-
Smartest Doc Challenge
MDLinx
Lung Cancer Clinical Pearls -
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools -
MDLinx Top Read
MDLinx
Running from that pile of unread journals? -
D Scott Cunningham MD, PhD
Site Editor, MDLinx
ASA reduces risk of ACS in hospitalized pneumonia patients -
Articles
Latest (3) Full Text Articles (79) Focus on Tuberculosis1 Cystic fibrosis-related diabetes compared to type 1 and type 2 diabetes in adults Diabetes/Metabolism Research and Reviews, May 24, 2013 Review Article
2 Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients Journal of Cystic Fibrosis, May 24, 2013 Clinical Article
3 Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis Clinical Microbiology and Infection, May 24, 2013 Review Article
Prior Articles
4 Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial Thorax, May 23, 2013 Clinical Article
5
Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema Full Text
BMC Pulmonary Medicine, May 23, 2013
Clinical Article
Exclusive Author Commentary
6 Risk factors for bronchiectasis in children with cystic fibrosis New England Journal of Medicine, May 23, 2013 Evidence Based Medicine Clinical Article
7 Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs Infection and Immunity, May 23, 2013 Clinical Article
8 Benefits of combining inspiratory muscle with ‘whole muscle’ training in children with cystic fibrosis: a randomised controlled trial British Journal of Sports Medicine, May 21, 2013 Evidence Based Medicine
9 Next generation diagnostics of cystic fibrosis and CFTR-related disorders by targeted multiplex high-coverage resequencing of CFTR Journal of Medical Genetics, May 21, 2013 Review Article
10 Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial European Respiratory Journal , May 20, 2013 Clinical Article
11
Aortopulmonary collateral flow in cystic fibrosis assessed with phase-contrast MRI
Pediatric Radiology, May 17, 2013
Clinical Article
Exclusive Author Commentary
12 Mitochondrial OXPHOS function is unaffected by chronic azithromycin treatment Journal of Cystic Fibrosis, May 16, 2013 Clinical Article
13 Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan - A Parallel, Randomized Trial Annals of Internal Medicine, May 15, 2013 Clinical Article
14 Phenotyping adults with non-cystic fibrosis bronchiectasis: A prospective observational cohort study Respiratory Medicine, May 15, 2013 Clinical Article
15 Cystic fibrosis and fertility Current Opinion in Obstetrics and Gynecology, May 15, 2013 Clinical Article
16 Stunting is an independent predictor of mortality in patients with cystic fibrosis Clinical Nutrition, May 15, 2013 Review Article
17 Skin pretreatment with microneedles prior to pilocarpine iontophoresis increases sweat production Clinical Physiology and Functional Imaging, May 15, 2013 Clinical Article
18 Non-invasive ventilation for cystic fibrosis Cochrane Reviews, May 14, 2013 Evidence Based Medicine Clinical Article
19 Cystic fibrosis in the era of genomic medicine Current Opinion in Pediatrics, May 14, 2013 Review Article
20 Comparison of Lung Clearance Index Measured During Helium Washin and Washout in Children With Cystic Fibrosis Pediatric Pulmonology, May 14, 2013 Clinical Article
Clinical Pearls in Pulmonology
- Chloral hydrate is a sedative that might be used to promote sleep in your pediatric migraine patients.
- Along with cough variant asthma and nasal disease, gastroesophageal reflux is considered one of three main causes of chronic cough.
- Trazodone does not improve sleep for methadone-maintained persons with sleep disturbance.
Highlights in Pulmonology
Simvastatin has a modest effect on Streptococcus pneumoniae infections
Using a murine mouse model of pneumonia, prolonged simvastatin therapy has a measureable effect on Streptococcus pneumoniae infection, but no effect on mortality. Mice were treated with simvastatin (1 mg/kg/d [low dose] or 10 mg/kg/d [high dose]) for 4 weeks, then infected with S. pneumoniae intrathecally. Mice treated with the high-dose regimen had less lung consolidation, decreased macrophage and neutrophil infiltration, decreased MCP-1, KC, and ICAM-1 production, and decreased bacterial titers in the blood 36 and 42 h post-infection. Despite these favorable physiologic effects, there was no effect on mortality compared to control mice treated with ampicillin 48 h post-infection.
Read the article summaryLow D-dimer levels identify low-risk patients with community-acquired pneumonia
As published in the European Journal of Internal Medicine, there were no mortalities in patients with community-acquired pneumonia (CAP) and low levels of D-dimer (< 500 ug/l). Of 147 patients in the study, D-dimer levels were elevated in those with severe CAP (2166 vs. 1630 ug/l), day 30-clinical failure (2228 vs. 1594 ug/l), early failure (2499 vs. 1669 ug/l), and non-survivors (3025 vs. 1680 ug/l). Importantly, D-dimer levels were not shown to be associated with clinical outcome based on multivariate analysis.
Read the article summaryBacteremia increases mortality risk in pneumococcal pneumonia
As published in the Journal of Infection, 114 of 981 (11.6%) of patients with pneumococcal pneumonia were bacteremic. Risk factors for bacteremia included immunosuppressants, age < 65 years, and diabetes mellitus. Patients with pneumococcal pneumonia and bacteria were at increased risk for mortality (28.6% vs. 8.5%). The combination of bacteremia, cerebrovascular disease, and septic shock had a strong association with mortality in patients with pneumococcal pneumonia.
Read the article summaryMost Popular Pulmonology Articles
Last month's top read Top Articles of 20121 Physical activity levels of patients with cystic fibrosis hospitalised with an acute respiratory exacerbation Respiratory Medicine, April 23, 2013
2 Lung Transplantation in Patients With Cystic Fibrosis Transplantation Proceedings, April 26, 2013 Review Article
3 Beta-blocker management of refractory hemoptysis in cystic fibrosis: a novel treatment approach Therapeutic Advances in Respiratory Disease, April 1, 2013 Review Article
4 Development and Validation of a Cystic Fibrosis Patient and Family Member Experience of Care Survey Quality Management in Health Care , April 11, 2013
5 Update on cystic fibrosis-related diabetes Journal of Cystic Fibrosis, April 19, 2013 Review Article
6 Tobramycin is a suppressor of premature termination codons Journal of Cystic Fibrosis, April 4, 2013
7 Factors associated with FEV1 decline in cystic fibrosis: analysis of the data of the ECFS Patient Registry European Respiratory Journal , April 22, 2013
8 The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis Respiratory Research, April 16, 2013 Free full text Review Article
9 Magnetic Resonance Imaging of Cystic Fibrosis Lung Disease Journal of Thoracic Imaging, April 29, 2013 Review Article
10 Automated quantification of radiologic patterns predicts survival in idiopathic pulmonary fibrosis European Respiratory Journal , April 8, 2013
11 Effect of supervised training on FEV1 in cystic fibrosis: A randomised controlled trial Journal of Cystic Fibrosis, April 16, 2013
12 Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis: The BAT Randomized Controlled Trial JAMA, March 27, 2013 Evidence Based Medicine
13 Pulmonary hypertension is a mild comorbidity in end-stage cystic fibrosis patients The Journal of Heart and Lung Transplantation, April 15, 2013
14 A review of renal disease in cystic fibrosis Journal of Cystic Fibrosis, April 25, 2013 Review Article
15 Approach to acute exacerbation of idiopathic pulmonary fibrosis Annals of Thoracic Medicine, April 4, 2013 Free full text Review Article
16 Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis Cochrane Reviews, March 19, 2013 Evidence Based Medicine
17 Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis Thorax, February 21, 2013
18 A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care Pediatric Pulmonology, January 9, 2013
19 Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis Current Opinion in Pharmacology , April 25, 2013 Review Article
20 A Preliminary Evaluation of the Effectiveness of the Cystic Fibrosis Foundation Mentoring Program for Respiratory Care Respiratory Care, April 29, 2013 Free full text
Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicine more
Other Topics in Pulmonology
Register now to view all the MDLinx contents (FREE)!
- Stay current on the latest literature, research and clinical news
- Get special communications and offers from MDLinx and our sponsors
- Receive invitations to paid market research
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close